| |
| Merck announces positive results from phase 2 KeyVibe-002 trial evaluating coformulation of vibostolimab pembrolizumab in previously treated patients with metastatic NSCLC |
| Editor:xuezhe Clicks:0 Date:2023-12-8 14:56:51 |
| Keyword: Merck |
| Healthoo Information: |
|
Merck announces positive results from phase 2 KeyVibe-002 trial evaluating coformulation of vibostolimab pembrolizumab in previously treated patients with metastatic NSCLC
|
|
|
|
|
